News

Obita Secures Major Investment to Revolutionize Payments

Obita Secures Major Investment to Revolutionize Payments

Obita Secures Major Investment to Transform Payment Infrastructure

Obita, a leading enterprise-level cross-border payment and digital financial network, revealed its successful completion of an angel round financing that secured over US$10 million. This financing round, co-led by Vision Plus Capital and Mirana Ventures, attracted participation from several notable institutions such as Legend Capital and HashKey Capital, as well as individual investors. The funding will be utilized for research and development, compliance infrastructure enhancements, and global market expansion, thereby accelerating the deployment of its stablecoin-based cross-border payment network.

Revolutionizing Cross-Border Payments

In light of the global advancements in stablecoin regulation and compliance, the landscape of cross-border payments is transforming rapidly. Obita’s blockchain-native payment network, developed under the framework of Obita Mesh, is designed to empower global enterprises by providing low-cost, real-time settlements backed by regulatory-compliant solutions. The network addresses significant industry challenges, including high foreign exchange costs, delayed settlements, and a lack of transparency in fund flows.

Through integration of enterprise-grade compliance systems, a cross-border clearing network, and unified treasury management tools, Obita is set to redefine capital movement for industries associated with cross-border trade, e-commerce, and supply chain management.

Leadership and Expertise Driving Innovation

Speaking on this transformative initiative, Dayong ZHANG, Co-founder and CEO of Obita, stated, “Cross-border payments are at a pivotal moment propelled by stablecoin innovation. Our goal is to utilize blockchain technology’s revolutionary power to enhance global capital flow via our comprehensive, compliant services.”

Yiran LIU, Managing Partner at Vision Plus Capital, added, “Cross-border B2B payment systems form the backbone of global trade. The innovative stablecoin-centered solution that Obita offers greatly enhances cost efficiency.” LIU expressed confidence in the Obita team’s extensive experience in global fintech and their broad cross-sector knowledge.

Expert Team Delivering Strategic Vision

The management team at Obita is assembled from top professionals in fintech, cross-border payments, and the digital asset sectors. They possess exceptional technical skills and a forward-looking vision that emphasizes innovation and responsiveness to market needs.

At the helm, Dayong ZHANG has established himself as a prominent leader in fintech and global payments. His prior roles have equipped him with the experience needed to manage complex financial products and led to significant advancements in compliance and regulatory frameworks. Moreover, Vincent YANG, Co-founder and CBO of Obita, is recognized for his strategic foresight in global market operations, having led various digital financial projects across numerous continents.

Strategic Partnerships Enhancing Capabilities

Industry leaders are optimistic about Obita’s prospects. David Toh, Managing Partner of Mirana Ventures, noted that “By embedding compliant stablecoin solutions into global trade frameworks, Obita is initiating significant upgrades within the payment industry.” This sentiment is echoed by other investors who see Obita’s approach as a pathway to further innovation in digital asset infrastructure.

Chao DENG, CEO of HashKey Capital, stated that Obita’s solution aligns perfectly with their vision of advancing digital asset engagement, compliance, and infrastructure solutions—their collaboration is set to spur transformative changes within the financial landscape.

The Future of Global Financial Connectivity

Obita’s vision is clear: to redefine global financial systems through compliant, blockchain-centric solutions. Positioned at the helm of the stablecoin-powered digital finance movement, the company enjoys robust backing from a seasoned team and an expansive network of strategic investors. This pivotal moment will not only enhance Obita's operational reach but will facilitate real-world adoption in key growing markets.

As they roll out their innovative payment solutions, Obita is poised to significantly influence the future dynamics of cross-border transactions, ensuring that businesses can engage more efficiently and economically across borders.

About Obita

Obita serves as a global B2B financial infrastructure and digital finance network, enabling stablecoin-driven transactions for enterprises, merchants, and fintech companies worldwide. The dedicated team is committed to fostering seamless financial exchanges, thereby redefining how businesses handle cross-border payments.

Frequently Asked Questions

What is Obita’s core business model?

Obita focuses on creating a stablecoin-powered cross-border payment network aimed at improving transaction efficiency and cost-effectiveness.

Who are the major investors in Obita's recent financing round?

The financing round was co-led by Vision Plus Capital and Mirana Ventures, with support from other notable investors.

What challenges does Obita aim to address in cross-border payments?

Obita seeks to tackle high foreign exchange costs, delayed settlements, and a lack of transparency in fund flows.

How does Obita's technology enhance payment solutions?

Obita leverages blockchain technology to create a compliant, efficient, and traceable payment network for businesses involved in global trade.

What industries can benefit from Obita’s services?

Industries such as e-commerce, supply chain management, and cross-border trade will significantly benefit from Obita’s innovative payment solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cytokinetics Faces Class Action: What You Need to Know

Updated Category News Views 175

Understanding the Class Action Lawsuit Against Cytokinetics Cytokinetics, Incorporated is currently facing a significant class action lawsuit initiated by shareholders. This legal challenge brings to light serious allegations against the Company regarding their disclosures and expectations for FDA approval of a key drug. Details of the Allegations The lawsuit asserts that...

Continue Reading
Discover the Embodied Luxury of the Champagne Specialist Course

Updated Category News Views 207

Verona Hosts the Esteemed Champagne Specialist Course The Italian Wine Academy is excited to announce a remarkable opportunity for wine enthusiasts and professionals. In Verona, for the very first time, the Academy will conduct the prestigious Comité Champagne 'Champagne Specialist' course. This unique program will be available in both English and Italian, providing an...

Continue Reading
MiniLuxe Achieves Strong Q1 2025 Growth with Strategic Focus

Updated Category News Views 378

MiniLuxe Reports Strong Financial Performance for Q1 2025 Reported figures all in U.S. Dollars MiniLuxe Holding Corp. (TSXV: MNLX) has announced exciting financial results for its first quarter of the year. This period showcased a significant 9% growth in revenue, reaching an impressive $6.1 million. Coupled with a gross profit of $2.5 million, reflective of a 12%...

Continue Reading
Transforming Shopify: AI Product Discovery for Enterprises

Updated Category News Views 141

Fredhopper's New App for Shopify Fredhopper Introduces Cutting-Edge Product Discovery Solutions The ecommerce landscape is evolving rapidly, and innovation is at the forefront. Fredhopper has launched its Product Discovery App for Shopify, bringing advanced AI-powered product search and personalized recommendations directly into the hands of enterprise merchants. This...

Continue Reading
Quantum Computing Inc. Faces Class Action Lawsuit for Shareholders

Updated Category News Views 162

Understanding the Recent Class Action Against Quantum Computing Inc. In a significant turn of events, Quantum Computing Inc. has come under legal pressure as a class action lawsuit has been filed on behalf of its shareholders. The lawsuit comes in response to allegations of misleading information that may have adversely affected investors' financial interests. Class...

Continue Reading